204 related articles for article (PubMed ID: 3469936)
1. Oral methotrexate is as effective as intramuscular in maintenance therapy of acute lymphoblastic leukaemia.
Chessells JM; Leiper AD; Tiedemann K; Hardisty RM; Richards S
Arch Dis Child; 1987 Feb; 62(2):172-6. PubMed ID: 3469936
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of oral and intramuscular methotrexate in children with acute lymphoblastic leukaemia.
Pearson AD; Mills S; Amineddine HA; Long DR; Craft AW; Chessells JM
Cancer Chemother Pharmacol; 1987; 20(3):243-7. PubMed ID: 3315283
[TBL] [Abstract][Full Text] [Related]
3. The influence of serum methotrexate concentrations and drug dosage on outcome in childhood acute lymphoblastic leukaemia.
Pearson AD; Amineddine HA; Yule M; Mills S; Long DR; Craft AW; Chessells JM
Br J Cancer; 1991 Jul; 64(1):169-73. PubMed ID: 1854617
[TBL] [Abstract][Full Text] [Related]
4. Medical Research Council leukaemia trial--UKALL V: an attempt to reduce the immunosuppressive effects of therapy in childhood acute lymphoblastic leukemia. Report to the Council by the Working Party on Leukaemia in Childhood.
Chessells JM; Durrant J; Hardy RM; Richards S
J Clin Oncol; 1986 Dec; 4(12):1758-64. PubMed ID: 3537216
[TBL] [Abstract][Full Text] [Related]
5. Neurotoxicity in lymphoblastic leukaemia: comparison of oral and intramuscular methotrexate and two doses of radiation.
Chessells JM; Cox TC; Kendall B; Cavanagh NP; Jannoun L; Richards S
Arch Dis Child; 1990 Apr; 65(4):416-22. PubMed ID: 2346334
[TBL] [Abstract][Full Text] [Related]
6. Improvement in treatment for children with acute lymphoblastic leukaemia. The Medical Research Council UKALL trials, 1972-84. Report to the Council by the Working Party on Leukaemia in Childhood.
Lancet; 1986 Feb; 1(8478):408-11. PubMed ID: 2868339
[TBL] [Abstract][Full Text] [Related]
7. Treatment of acute lymphoblastic leukaemia. Comparison of immunotherapy (B.C.G.), intermittent methotrexate, and no therapy after a five-month intensive cytotoxic regimen ((Concord trial). Preliminary report to the Medical Research Council by the Leukaemia Committee and the Working Party on Leukaemia in Childhood.
Br Med J; 1971 Oct; 4(5781):189-94. PubMed ID: 4940157
[TBL] [Abstract][Full Text] [Related]
8. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial.
Nielsen SN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Hjalgrim LL; Schmiegelow K
Lancet Oncol; 2017 Apr; 18(4):515-524. PubMed ID: 28258828
[TBL] [Abstract][Full Text] [Related]
9. Serum profiles of methotrexate after its administration in children with acute lymphoblastic leukaemia.
Pinkerton CR; Welshman SG; Bridges JM
Br J Cancer; 1982 Feb; 45(2):300-3. PubMed ID: 6949608
[No Abstract] [Full Text] [Related]
10. Intensive oral methotrexate protects against lymphoid marrow relapse in childhood B-precursor acute lymphoblastic leukemia.
Winick N; Shuster JJ; Bowman WP; Borowitz M; Farrow A; Jacaruso D; Buchanan GR; Kamen BA
J Clin Oncol; 1996 Oct; 14(10):2803-11. PubMed ID: 8874342
[TBL] [Abstract][Full Text] [Related]
11. New treatment schedule with improved survival in childhood leukemia. Intermittent parenteral vs daily oral administration of methotrexate for maintenance of induced remission. Acute leukemia group B.
JAMA; 1965 Oct; 194(1):75-81. PubMed ID: 5896942
[No Abstract] [Full Text] [Related]
12. Prognostic importance of myelosuppression during maintenance treatment of lymphoblastic leukaemia. Leukaemia in Childhood Working Party of the Medical Research Council.
Dolan G; Lilleyman JS; Richards SM
Arch Dis Child; 1989 Sep; 64(9):1231-4. PubMed ID: 2684039
[TBL] [Abstract][Full Text] [Related]
13. Analysis of treatment in childhood leukaemia. I. Predisposition to methotrexate-induced neutropenia after craniospinal irradiation. Report to the Medical Research Council of the Working Party on Leukaemia in Childhood.
Br Med J; 1975 Sep; 3(5983):563-6. PubMed ID: 1100179
[TBL] [Abstract][Full Text] [Related]
14. Treatment of acute lymphoblastic leukemia in childreq with "prophylactic" intrathecal methotrexate and intensive systemic chemotherapy.
Haghbin M; Tan CT; Clarkson BD; Miké V; Burchenal JH; Murphy ML
Cancer Res; 1975 Mar; 35(3):807-11. PubMed ID: 1054287
[TBL] [Abstract][Full Text] [Related]
15. Intermediate-dose methotrexate in the treatment of childhood acute lymphocytic leukaemia: lack of benefit during maintenance therapy following intensive induction therapy.
Janka-Schaub GE; Winkler K; Jürgens H; Goebel U; Gutjahr P; Spaar HJ
Eur J Pediatr; 1986 Apr; 145(1-2):14-7. PubMed ID: 3525176
[TBL] [Abstract][Full Text] [Related]
16. [Acute lymphoblastic leukemia in children. Long survivals obtained with protocols C2-72 and D-74 (1972-1977)].
Ortega JJ; Javier G; Montagut JM; Torán N
An Esp Pediatr; 1986 Feb; 24(2):87-97. PubMed ID: 3516041
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of two methods of maintenance chemotherapy with methotrexate and 6-mercaptopurine for childhood acute lymphoblastic leukemia].
Kawai S; Fujimoto T; Hiyoshi Y; Nibu K; Ito M; Kadoya S; Shingaki Y
Rinsho Ketsueki; 1984 Jun; 25(6):819-26. PubMed ID: 6384569
[No Abstract] [Full Text] [Related]
18. Treatment and outcome of acute lymphoblastic leukaemia (ALL) in children.
Boon WH; Chan M; Vellayappan K; Khor M; Mui LC; Boon CK
J Singapore Paediatr Soc; 1977 Jun; 19(2):71-8. PubMed ID: 270007
[No Abstract] [Full Text] [Related]
19. [Treatment of childhood acute lymphoblastic leukemia: efficacy of intermittent pulses of 6-mercaptopurine and methotrexate for maintenance chemotherapy, CCLSG-S811 (phase III study). Children's Cancer and Leukemia Study Group].
Koizumi S; Fujimoto T; Takeda T; Yatabe M; Katou K; Kaneko A; Sekine I; Takeshita T; Utsumi J; Kubota H
Rinsho Ketsueki; 1987 Aug; 28(8):1375-84. PubMed ID: 3323563
[No Abstract] [Full Text] [Related]
20. Oral methotrexate/6-mercaptopurine may be superior to a multidrug LSA2L2 Maintenance therapy for higher risk childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.
Schmiegelow K; Heyman M; Kristinsson J; Mogensen UB; Rosthøj S; Vettenranta K; Wesenberg F; Saarinen-Pihkala U;
J Pediatr Hematol Oncol; 2009 Jun; 31(6):385-92. PubMed ID: 19648786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
